Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Down 1.8 %

AVGR stock opened at $0.56 on Thursday. The company has a market capitalization of $1.85 million, a P/E ratio of -0.05 and a beta of 1.10. The company has a 50-day simple moving average of $0.72 and a 200 day simple moving average of $0.93. Avinger has a fifty-two week low of $0.39 and a fifty-two week high of $5.45.

Avinger (NASDAQ:AVGR) last posted its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, topping the consensus estimate of ($2.03) by $0.21. The business had revenue of $1.65 million during the quarter, compared to the consensus estimate of $1.60 million. Avinger had a negative net margin of 261.06% and a negative return on equity of 5,527.11%. During the same quarter in the prior year, the company posted ($2.92) earnings per share. Equities analysts anticipate that Avinger will post -4.69 EPS for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.